Dr. Said R. Beydoun, MD
- Medicare services, 2024
- 527
- Medicare patients, 2024
- 195
- Part D claims, 2024
- 484
- Publications
- 19
- Clinical trials
- 16
- Practice address
- 1500 San Pablo Street, Los Angeles, CA 90033
- Practice phone
- Call (323) 442-8656
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Beydoun's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Said R. Beydoun is a clinical neurophysiologist in Los Angeles, California
Dr. Beydoun practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.
Dr. Beydoun's NPI, 1700827482, was assigned on June 10, 2006. Dr. Beydoun graduated from American University of Beirut Faculty of Medicine in 1980. Dr. Beydoun holds California license C40914.
- NPI
- 1700827482NPI Registry (opens in a new tab)
- Medicare PAC ID
- 8325941222
- NPI enumeration date
- June 10, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (323) 442-8656
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 72
- Medical school graduation
- 1980
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Said R. Beydoun practices at Keck Hospital of USC in Los Angeles, California
Dr. Beydoun's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.
- Keck Hospital of USC1500 San Pablo Street, Los Angeles, CA 90033 · Los Angeles CountyPhone(323) 442-8656
Source: Dmand AI Affiliation Data
Dr. Said R. Beydoun is affiliated with 5 sites of care and 1 medical group
Dr. Beydoun's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Beydoun is also affiliated with USC Verdugo Hills Hospital. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Beydoun to 1 more group practice or clinic, 1 other site and 1 urgent care center, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Said R. Beydoun's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beydoun practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Keck Hospital of USC | Available with a free account |
| +4 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Southern California and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Said R. Beydoun is one of 55 clinical neurophysiologists in California
Clinical neurophysiology is Dr. Beydoun's primary specialty in the NPI Registry, under taxonomy code 2084N0600X. Dr. Beydoun is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Beydoun's licenses on file in 2 states: California and Florida.
Specialties and state licenses
- Clinical neurophysiology, CaliforniaPrimary
- Florida license
Clinical focus
Dmand AI lists carpal tunnel syndrome, fibromyalgia and chronic pain, hereditary polyneuropathy, lower back pain, mobility impairment, muscle disease, muscle weakness and neck pain and spine problems among the conditions Dr. Beydoun treats.
Clinical neurophysiologists near Dr. Beydoun
Counts of clinical neurophysiologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Said R. Beydoun billed Medicare for 527 services in 2024
CMS data shows 527 Medicare services from Dr. Beydoun across 9 procedure codes in 2024, for 195 Medicare patients. Medicare paid $45,264 for them.
Dr. Beydoun's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3252024: 35910%
- Tests and treatments
- 2023: 4122024: 16859%
Where Dr. Beydoun's Medicare services took place, 2024
- In an office12824%
- In a facility39976%
Dr. Beydoun compared with the California median for clinical neurophysiologists, 2024
- Dr. Beydoun
- California median
- Medicare services
- 527vs 502Close to median
- Medicare patients
- 195vs 14634% above
- Part D claims
- 384vs 34810% above
Medians across 50 clinical neurophysiologists in California with Dmand AI profiles that report each measure.
Dr. Beydoun's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Beydoun?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Beydoun and other clinical neurophysiologists in California.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Said R. Beydoun treated 195 Medicare patients in 2024, average age 73
CMS counts 195 Medicare patients who saw Dr. Beydoun in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Beydoun's median patient age at 71, with 44% women.
Dr. Beydoun's Medicare patients by age, 2024
Dr. Beydoun's Medicare patients by sex, 2024
- Women7438%
- Men12162%
Chronic conditions among Dr. Beydoun's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis70%
- Diabetes39%
- Ischemic heart disease36%
- Chronic kidney disease27%
- Atrial fibrillation24%
- Mood disorders24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Beydoun's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women44%
- Men56%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Said R. Beydoun wrote 484 Medicare Part D claims in 2024
In 2024, Dr. Beydoun wrote 484 Medicare Part D claims for 59 patients. 21% of them were for generic drugs. CMS names the drug for 384 of them, across 10 drugs with 11 or more claims each, at $3,937,911 in total drug cost. In 2023, CMS named 552 claims across 13 drugs.
Dr. Beydoun's Part D claims by kind of drug, 2024
- Generic100 claims21%
- Brand-name384 claims79%
Dr. Beydoun's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 5522024: 38430%
Drugs named by CMS: 10 in 2024, 13 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Said R. Beydoun offers telehealth to Medicare patients
Dr. Beydoun accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Beydoun as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Said R. Beydoun has 19 publications on record
Dmand AI links 19 papers to Dr. Beydoun, published from 2009 to 2025. 2010 was the busiest year, with 2. Dr. Beydoun's most frequent co-authors are Richard Alan Rison, MD, Michael Benatar, MD and Carlayne E. Jackson, MD.
Dr. Beydoun's papers by year, 2009 to 2025
Dr. Beydoun's most frequent co-authors
- Richard Alan Rison, MD6 shared papers
- Michael Benatar, MD3 shared papers
- Carlayne E. Jackson, MD3 shared papers
Recent publications by Dr. Beydoun
JAMA Netw Open
See who Dr. Beydoun researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Beydoun works with, so you can find a warm path to the right clinical neurophysiologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Said R. Beydoun has worked on 16 clinical trials
Dmand AI links Dr. Beydoun to 16 clinical trials, 9 of them phase 3 studies. Conditions studied include Myasthenia Gravis, Neuromuscular Junction Diseases and Polyradiculoneuropathy, Chronic Inflammatory Demyelinating. Alexion Pharmaceuticals, Inc. sponsors the most, 3.
Clinical trials with Dr. Beydoun by phase
- NonePhase 1: no trials
- 6Phase 2: 6 trials
- 1Phase 2/3: 1 trial
- 9Phase 3: 9 trials
- NonePhase 4: no trials
Conditions in Dr. Beydoun's trials
- Myasthenia Gravis
- Neuromuscular Junction Diseases
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
- Polyradiculoneuropathy
- Amyotrophic Lateral Sclerosis
Investigators on the most trials with Dr. Beydoun
- Mohammad Alsharabati, MD3 shared trials
- Pei S. Liu, MD3 shared trials
- Mazen M. Dimachkie, MD1 shared trial
Recent clinical trials with Dr. Beydoun
An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness (opens in a new tab)
Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis) (opens in a new tab)
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG (opens in a new tab)
Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS) (opens in a new tab)
Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Said R. Beydoun received $1,216,000 in industry payments from 2016 to 2025
CMS Open Payments shows 1,204 general payments to Dr. Beydoun from 27 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Alexion Pharmaceuticals, Inc. paid the most, $199,970. It also lists 4 research payments totaling $5,250 from 2020 to 2022.
General payments to Dr. Beydoun by program year, 2016 to 2025
General payments to Dr. Beydoun by kind, 2016 to 2025
- Speaker and faculty fees$657,16354%
- Consulting fees$226,84219%
- Honoraria$209,39817%
- Travel and lodging$90,3177%
- Other$32,2803%
Companies that paid Dr. Beydoun the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Said R. Beydoun has 3 awards and honors on record
Dmand AI lists 3 awards for Dr. Beydoun, most recently Top Doctors:LA Area in 2013.
Awards and honors for Dr. Beydoun
- 2013
- Top Doctors:LA Area
- 2012
- Top Doctors:Southern California
- Undated
- Super Doc
Source: Dmand AI Professional Profile Data
Dr. Said R. Beydoun graduated from American University of Beirut Faculty of Medicine
Dr. Beydoun graduated from American University of Beirut Faculty of Medicine in 1980. Dr. Beydoun is a member of AAN and AANEM.
- Medical school
- Board certified in clinical neurophysiology
- Board certified in neurology
- Board certified in neuromuscular medicine
- Board certified in pain medicine
Source: Dmand AI Professional Profile Data
Dr. Said R. Beydoun accepts plans from 9 insurance carriers
Dr. Beydoun is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.
- Aetna
- Elevance
- Blue Cross Blue Shield of Michigan
- Blue Cross Blue Shield of Massachusetts
- HCSC
- LA Care
- Regence Health Plans
- CMS Medicare
- +1 more carriersWith a free account
Plan types Dr. Beydoun accepts, by number of carriers
- Medicare8
- PPO6
- HMO4
- POS3
- EPO2
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Said R. Beydoun's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Said R. Beydoun
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Said R. Beydoun's NPI number?
Dr. Said R. Beydoun's NPI number is 1700827482. It was assigned on June 10, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Said R. Beydoun?
Dr. Said R. Beydoun is a clinical neurophysiologist in Los Angeles, California. The primary specialty in the NPI Registry is Clinical Neurophysiology Physician (taxonomy code 2084N0600X).
Where does Dr. Said R. Beydoun practice?
Dr. Beydoun practices at 1500 San Pablo Street, Los Angeles, CA 90033. Dr. Beydoun's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dmand AI also links Dr. Beydoun to 1 group practice or clinic, 1 other site and 1 urgent care center.
What is Dr. Said R. Beydoun's office phone number?
The practice phone on file for Dr. Beydoun is (323) 442-8656.
What is Dr. Said R. Beydoun's medical license number?
Dr. Beydoun holds California license C40914, one of the licenses on file in 2 states.
Which states has Dr. Said R. Beydoun been licensed in?
Dmand AI has state licenses on file for Dr. Beydoun in California (1983 to 2026) and Florida (1982 to 1998).
Which hospitals is Dr. Said R. Beydoun affiliated with?
Dr. Beydoun practices at Keck Hospital of USC in Los Angeles, California. Dr. Beydoun is also affiliated with USC Verdugo Hills Hospital.
What medical group is Dr. Said R. Beydoun part of?
Dr. Beydoun is linked to USC Care Medical Group.
Does Dr. Said R. Beydoun accept Medicare?
Yes. CMS data shows Dr. Beydoun billed Medicare for 527 services in 2024, and Dr. Beydoun accepts Medicare assignment.
Does Dr. Said R. Beydoun offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Beydoun as offering telehealth services.
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Said R. Beydoun see?
CMS counts 195 Medicare patients who saw Dr. Beydoun in 2024, with an average age of 73.
Is Dr. Said R. Beydoun board certified?
Yes. Dr. Beydoun is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology.
What services does Dr. Said R. Beydoun bill to Medicare?
In 2024, Dr. Beydoun's most billed Medicare services were office visit, established patient (99215), office visit, established patient (99214) and nerve and brain test (95885).
Where did Dr. Said R. Beydoun go to medical school?
Dr. Beydoun graduated from American University of Beirut Faculty of Medicine in 1980.
What drugs does Dr. Said R. Beydoun prescribe most?
In 2024 Medicare Part D data, Dr. Beydoun's most prescribed drugs by claims were Gamunex-C, Radicava Ors and Privigen.
Has Dr. Said R. Beydoun received payments from drug or device companies?
CMS Open Payments shows $1,216,000 in general payments to Dr. Beydoun from 27 companies from 2016 to 2025. The largest total came from Alexion Pharmaceuticals, Inc.
How long has Dr. Said R. Beydoun been practicing?
Dr. Beydoun graduated from medical school in 1980, 46 years ago.
Does Dr. Said R. Beydoun do research?
Dmand AI links 19 publications to Dr. Beydoun, published from 2009 to 2025. Dr. Beydoun has worked on 16 clinical trials.
Who does Dr. Said R. Beydoun publish with?
Dr. Beydoun's most frequent co-authors are Richard Alan Rison, MD (6 shared papers), Michael Benatar, MD (3 shared papers) and Carlayne E. Jackson, MD (3 shared papers).
What insurance does Dr. Said R. Beydoun accept?
Dr. Beydoun is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.
Selling to clinical neurophysiology practices?
See clinical neurophysiologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card